Skip to main

Neuroendocrine Tumors Research

Winship is a leader in the research of neuroendocrine tumors. We provide access to treatment options that aren’t available anywhere else.

Researching Neuroendocrine Tumors Developing Novel Therapies at Winship

Cancer survival rates are improving all the time, thanks to research being done at leading cancer centers like Winship Cancer Institute of Emory University.

We’re honored to be one of only a few dozen National Cancer Institute (NCI)–designated Comprehensive Cancer Centers in the country — and the only one in Georgia — developing lifesaving cancer and, more specifically, neuroendocrine cancer research initiatives.

Neuroendocrine Tumors Research at Winship

Winship is one of the top neuroendocrine cancer research centers in the U.S. In fact, many drugs approved by the FDA to treat neuroendocrine cancer came out of clinical trials performed right here in Atlanta. We’re currently involved in neuroendocrine cancer research to develop better methods of detecting and diagnosing neuroendocrine tumors as well as therapies for high-grade neuroendocrine tumors. And we continue to publish research findings on peptide receptor radionuclide therapy since pioneering the use of the nuclear medicine therapy nationally.

We also conduct what is called outcomes research, which involves analyzing massive amounts of data to identify which treatments are working and which aren’t for various types of neuroendocrine cancer in patients across the country. We then use the data we gather to inform our treatment decisions.

Winship’s neuroendocrine cancer researchers are leading the way and changing how the world prevents, detects, diagnoses, treats and survives neuroendocrine cancer. We pioneer discoveries in the lab that are translated into the latest, most effective treatments in the clinic. Our bench-to-bedside neuroendocrine cancer research enables us to discover, develop and deliver game-changing procedures, technologies, diagnostics and treatments.

Neuroendocrine Tumors Clinical Trials

Besides standard therapy, many Winship patients with neuroendocrine cancer are eligible to participate in a clinical trial. Clinical trials are controlled studies that test new interventions on a disease, such as neuroendocrine cancer. They offer participants early access to novel treatments that are not yet commercially available.

Participating in Neuroendocrine Cancer Research

Clinical trials are the third step of a five-step process for testing new therapies as outlined by the Food and Drug Administration. By the time a therapy comes to clinical trial, it has been tested in a laboratory setting and has passed preclinical safety standards.

As a neuroendocrine cancer research center, our physicians will make every effort to match you with a clinical trial that targets your unique cancer. It’s best if you enroll from the very beginning, so let your doctor know on your first visit if you’re interested in learning more about a clinical trial. Most clinical trials are supplemental, meaning you’ll still receive the standard therapy in addition to any treatment being studied.

Support for Clinical Trial Participation

Winship conducts neuroendocrine cancer research at the following locations:

We welcome trial participants from all over Georgia and throughout the Southeast. Talk with your doctor about whether you are eligible to participate in a clinical trial. Our supportive oncology team can assist you with services, such as finding affordable accommodations near Winship for the duration of your clinical trial.